N-(3-Indolylacetyl)-L-isoleucine
CAS57105-45-0
N-(3-Indolylacetyl)-L-isoleucine (CAS 57105-45-0, C16H20 N2 O3) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 57105-45-0
- Formula
- C16H20 N2 O3
- Mol. weight
- 288.34 g/mol
Chemical Specifications
Identifiers
| CAS number | 57105-45-0 |
|---|---|
| Product name | N-(3-Indolylacetyl)-L-isoleucine |
| Chinese name | N-(3-吲哚乙酰基)-L-异亮氨酸 |
| Synonyms | IAA-L-ILE |
| Chinese synonyms | N-(3-吲哚乙酰基)-L-异亮氨酸; N-(3-吲哚基乙酰基)-L-异亮氨酸 |
| Molecular formula | C16H20 N2 O3 |
| Molecular weight | 288.34 g/mol |
Physical and chemical properties
| Melting Point | 182-183 ( ℃ ) |
|---|---|
| Boiling Point | 311.4 ( ℃ ) |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of N-(3-Indolylacetyl)-L-isoleucine?
The CAS Registry Number of N-(3-Indolylacetyl)-L-isoleucine is 57105-45-0. N-(3-Indolylacetyl)-L-isoleucine is also known as IAA-L-ILE.
What is the molecular formula and molecular weight of N-(3-Indolylacetyl)-L-isoleucine?
The molecular formula of N-(3-Indolylacetyl)-L-isoleucine is C16H20 N2 O3, and its molecular weight is 288.34 g/mol.
How can I request a quotation for N-(3-Indolylacetyl)-L-isoleucine?
Send an inquiry for N-(3-Indolylacetyl)-L-isoleucine (CAS 57105-45-0) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for N-(3-Indolylacetyl)-L-isoleucine
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.